Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
about
The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysisAssociation of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndromeCTLA-4 (+49A/G) polymorphism and type-1 diabetes in Turkish childrenCTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donorAssociation of the +49 A/G Polymorphism of CTLA4 Gene with Idiopathic Recurrent Spontaneous Abortion in Women in Southwest of Iran.Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: evidence based on 58 studies.Association study of IL2RA and CTLA4 Gene Variants with Type I Diabetes Mellitus in children in the northwest of Iran.Cytotoxic T-lymphocyte-associated protein 4 +49A/G polymorphisms contribute to the risk of type 1 diabetes in children: An updated systematic review and meta-analysis with trial sequential analysis.Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children.CTLA4+49G allele associates with early onset of type 1 diabetes in North Indians.Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: a meta-analysis.CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.The Relationship between insulin variable number of tandem repeats (INS-VNTR) -23 A/T and cytotoxic Tlymphocyte associated protein-4 (CTLA-4) +49 A/G polymorphisms with islet autoantibodies in persons with diabetes.CTLA-4 +49 G/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell functionCytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT
P2860
Q33585054-35A03211-3A3B-4286-9450-AE8C3C890EDDQ34150405-385609F7-2BB3-44B2-835F-9B2117372E5BQ34824040-9D72FFBA-FE2B-453E-B3AA-38E91038D150Q36772160-A99DF9D4-EBDD-45CA-87E9-A7FC4F339A19Q36842615-BB7C9467-7892-47BC-A25F-75B165E05F9DQ37099555-2FA91BB1-5FC9-47FF-BD27-D90EE8CE913AQ37509820-87E730EB-4B0E-4C71-98BA-14D2AF5E9FA3Q37666989-48BE6C69-A4B3-4B82-9447-E7CCF1C9D0BAQ37705876-1685A72D-6317-45B3-9388-33E1D2B20739Q39272852-46BFC9E8-62C8-46F7-A1AA-414779BBCD07Q41344923-A4175F7A-F2E0-45EB-A799-101F9DC8B3FBQ42263268-C438EF51-28B1-48BA-908F-E32CEF2A6D4FQ47267543-D30F0191-CB5A-4D4E-8BA4-4A834F0ECCFBQ52728405-94F1358A-E267-4579-951C-C931B6B8F291Q55288585-E1925B34-33C8-4A44-8F43-124EAFEF0411Q56891252-74E7E991-3219-4609-9B3A-5961F67C815EQ56898457-4C4EBB63-C9E4-4D78-92F0-A25E18754A1F
P2860
Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@en
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@nl
type
label
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@en
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@nl
prefLabel
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@en
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@nl
P2093
P1433
P1476
Association of CTLA-4 polymorp ...... diabetes mellitus in children.
@en
P2093
Elena Carrasco
Francisco Pérez-Bravo
Iván Balic
P304
P356
10.1016/J.HUMIMM.2008.12.007
P577
2009-01-09T00:00:00Z